These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 30225159)
21. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging. Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132 [TBL] [Abstract][Full Text] [Related]
22. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer. Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684 [TBL] [Abstract][Full Text] [Related]
23. FANCF hypomethylation is associated with colorectal cancer in Han Chinese. Yu H; Pan R; Gao T; Wu D; Ying J; Duan S Turk J Gastroenterol; 2020 Aug; 31(8):558-565. PubMed ID: 32915143 [TBL] [Abstract][Full Text] [Related]
24. Promoter Methylation of Zhang L; Li D; Gao L; Fu J; Sun S; Huang H; Zhang D; Jia C; Zheng T; Cui B; Liu Y; Zhao Y Front Genet; 2022; 13():928150. PubMed ID: 36017498 [TBL] [Abstract][Full Text] [Related]
25. Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method. Rezvani N; Alibakhshi R; Vaisi-Raygani A; Bashiri H; Saidijam M Oncol Lett; 2017 May; 13(5):3277-3284. PubMed ID: 28521434 [TBL] [Abstract][Full Text] [Related]
26. DNA hypermethylated status and gene expression of Huang J; Tan ZR; Yu J; Li H; Lv QL; Shao YY; Zhou HH Onco Targets Ther; 2017; 10():4739-4751. PubMed ID: 29033587 [TBL] [Abstract][Full Text] [Related]
27. A panel of genes methylated with high frequency in colorectal cancer. Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021 [TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of Lin RK; Hung WY; Huang YF; Chang YJ; Lin CH; Chen WY; Chiu SF; Chang SC; Tsai SF Oncotarget; 2017 Dec; 8(69):113431-113443. PubMed ID: 29371920 [TBL] [Abstract][Full Text] [Related]
29. Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients. Savio AJ; Daftary D; Dicks E; Buchanan DD; Parfrey PS; Young JP; Weisenberger D; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B BMC Cancer; 2016 Feb; 16():113. PubMed ID: 26884349 [TBL] [Abstract][Full Text] [Related]
30. Detection of aberrant methylated SEPT9 and NTRK3 genes in sporadic colorectal cancer patients as a potential diagnostic biomarker. Behrouz Sharif S; Hashemzadeh S; Mousavi Ardehaie R; Eftekharsadat A; Ghojazadeh M; Mehrtash AH; Estiar MA; Teimoori-Toolabi L; Sakhinia E Oncol Lett; 2016 Dec; 12(6):5335-5343. PubMed ID: 28105243 [TBL] [Abstract][Full Text] [Related]
31. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients. Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485 [TBL] [Abstract][Full Text] [Related]
32. Methylation status of ADAM12 promoter are associated with its expression levels in colorectal cancer. Wang Y; Zhang J; Cao H; Han F; Zhang H; Xu E Pathol Res Pract; 2021 May; 221():153449. PubMed ID: 33930608 [TBL] [Abstract][Full Text] [Related]
33. DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter. Shao K; Pu W; Zhang J; Guo S; Qian F; Glurich I; Jin Q; Ma Y; Ju S; Zhang Z; Ding W Clin Epigenetics; 2021 Apr; 13(1):89. PubMed ID: 33892791 [TBL] [Abstract][Full Text] [Related]
34. Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer. Zhu Q; Jin Z; Yuan Y; Lu Q; Ge D; Zong M Scand J Gastroenterol; 2011 Apr; 46(4):436-45. PubMed ID: 21128871 [TBL] [Abstract][Full Text] [Related]
35. RASGRF1 Hypermethylation, a Putative Biomarker of Colorectal Cancer. Chen H; Xu Z; Yang B; Zhou X; Kong H Ann Clin Lab Sci; 2018 Jan; 48(1):3-10. PubMed ID: 29530990 [TBL] [Abstract][Full Text] [Related]
36. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion. Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123 [TBL] [Abstract][Full Text] [Related]
37. Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. Zhao H; Li Q; Wang J; Su X; Ng KM; Qiu T; Shan L; Ling Y; Wang L; Cai J; Ying J PLoS One; 2012; 7(11):e49683. PubMed ID: 23152928 [TBL] [Abstract][Full Text] [Related]
38. Alcohol induces cell proliferation via hypermethylation of ADHFE1 in colorectal cancer cells. Moon JW; Lee SK; Lee YW; Lee JO; Kim N; Lee HJ; Seo JS; Kim J; Kim HS; Park SH BMC Cancer; 2014 May; 14():377. PubMed ID: 24886599 [TBL] [Abstract][Full Text] [Related]
39. Methylation profile of promoter region of p16 gene in colorectal cancer patients of Kashmir valley. Wani HA; Beigh MA; Amin S; Bhat AA; Bhat S; Khan H; Mattoo AA; Showkat M; Masood A; Majid S J Biol Regul Homeost Agents; 2013; 27(2):297-307. PubMed ID: 23830381 [TBL] [Abstract][Full Text] [Related]
40. Feasibility of quantifying Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]